420 with CNW — Government-Funded Research Shows Including CBD While Making Dentures Staves Off Oral Infections

A recently published study suggests that integrating CBD into denture materials may help prevent oral infections. The research, which appeared last month in the journal Molecules and backed by government funding, indicates that incorporating CBD into dentures could provide an antibiotic-free method to reduce plaque buildup and improve oral hygiene.

To explore this possibility, scientists infused CBD into polymethyl methacrylate (PMMA), a plastic commonly used in dentures due to its durability and aesthetic appeal. They then evaluated its antimicrobial effects against three bacteria: Streptococcus agalactiae, Escherichia coli, and Staphylococcus aureus.

Findings revealed that CBD-coated dentures were highly effective in killing Gram-positive bacteria. While the coating did not eliminate free-floating Gram-negative bacteria, it successfully eradicated bacterial biofilms.

The study reported a remarkable 99% decrease in biofilm growth for Gram-negative and Gram-positive bacteria on CBD-treated PMMA compared to the standard material. Researchers noted that CBD caused bacterial cell walls to break down and be destroyed.

In certain instances, the contrast between normal and CBD-infused PMMA was striking. For instance, S. agalactiae growth was 10,000 times higher on regular PMMA than on the CBD-coated version. The research also documented a 99% drop in E. coli and S. aureus biofilms and an even greater 99.99% decrease in S. agalactiae biofilms.

One aspect requiring further examination is how to develop coatings that allow for a controlled and prolonged release of CBD to maximize its ability to combat bacteria over time. The researchers observed that CBD released rapidly within the first 12 hours before stabilizing and dispersing gradually in a controlled environment.

Another area for future investigation is why CBD coatings effectively eradicated biofilms but did not affect free-floating planktonic bacteria of the same species. The researchers suggest further research into the genetic mechanisms behind biofilm formation and maintenance, as well as the role of CBD in disrupting bacterial adhesion to surfaces.

These findings align with separate research that explored CBD’s antibacterial effects in other contexts.

One study found that CBD could help treat bacterial vaginosis by weakening Gardnerella vaginalis biofilms, which can disrupt the microbial balance in the vagina. Another study, published in Pharmaceuticals, suggested that CBD might have wound-healing and anti-aging properties, making it a valuable addition to skincare products.

As research into CBD’s medical applications continues, these studies highlight its potential as a natural antibacterial agent that could revolutionize dental and healthcare treatments.

These studies funded by the federal government are helping to confirm what is behind the popularity of marijuana brands and the mushrooming of ancillary enterprises like Innovative Industrial Properties Inc. (NYSE: IIPR) that have been established to address the niche needs of companies dealing directly in marijuana products.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Nebraska Former Governor, AG Ask Lawmakers to Disregard Ballot Decision Legalizing Medical Cannabis

Nebraska’s Attorney General Mike Hilgers and former Governor Pete Ricketts are asking the state legislature to reject two citizen-led initiatives concerning medical marijuana production, use, and possession. The measures were approved by about 70% of voters in the recent election.

In an opinion piece, Hilgers and Ricketts, now a U.S. Senator, urged lawmakers to disregard the voters’ decision stating that the legislature is not obligated to act on the matter. They expressed concerns over marijuana use, claiming it is harmful, prone to abuse, and unsafe even when used for medical purposes.

Ricketts, a long-time cannabis reform opponent, has previously made extreme claims, including saying that legalizing cannabis could put young people’s lives at risk. The Attorney General’s office warned that if regulators tried to license medical marijuana providers, the state would take legal action, alleging violations of federal law. Legalization opponents have sued to overturn the November election results.

Lawmakers recently heard arguments regarding a proposed law, Legislative Bill 483, which seeks to prevent patients from accessing cannabis in its natural form. Paul Armentano, Deputy Director of NORML, spoke against the measure, emphasizing that voters had clearly expressed their desire for regulated medical marijuana access.

He described the measure as both undemocratic and harmful to patients, explaining that restricting access to only pill or oral forms of cannabis could delay symptom relief for those experiencing nausea, pain, or muscle spasms.

Over 300 people provided testimony opposing LB 483.

Lawmakers also discussed separate measures aimed at refining regulations for medical marijuana access. Supporters of these initiatives, including the advocacy group Nebraskans for Medical Marijuana, gathered at the state capitol to protest efforts to overturn voter-approved measures. Despite extensive debate, no votes were cast on any cannabis-related legislation.

Armentano warned that the state’s attempt to override the election outcome is part of a broader trend seen in GOP-led states. He pointed to Ohio, where lawmakers recently pushed for new restrictions that rolled back voter-approved cannabis legalization, and South Dakota, where a similar attempt to repeal medical marijuana protections narrowly failed.

“In a democracy, different policy perspectives should be debated, and voters’ decisions should be respected,” Armentano stated. “But increasingly, opponents of cannabis reform are working to sideline voters entirely. Regardless of one’s stance on marijuana, these actions should be deeply concerning to anyone who values the democratic process.”

The cannabis industry, including enterprises like Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), is likely to be concerned by this growing trend in which lawmakers take steps to try and sideline what voters have decided during an election.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Texas Senators Consider an Outright THC Ban

A Senate committee in Texas recently reviewed a proposed measure that seeks to prohibit all types of THC. SB 3, supported by Lieutenant Governor Dan Patrick, addresses concerns over illegal THC products being sold statewide.

Patrick argues that businesses are taking advantage of a legal loophole to sell potentially harmful substances. In 2019, Texas legalized the production and sale of hemp through the Hemp Farming Act, which allowed for cannabis plants with no more than 0.3% delta-9 THC.

Some business owners acknowledge the need for stricter regulations, such as age restrictions, but believe an outright ban is excessive. According to Jazmin Torres, proprietor of Zenblendz, a smoke shop that sells THC products, a large portion of her clientele consists of elderly folks and veterans who use the products for wellness purposes rather than for recreational purposes. She worries a comprehensive ban would kill the sector.

Hometown Hero, a marijuana wholesaler based in Austin, also voiced concerns. A company representative emphasized that their products offer a safer alternative to alcohol and warned that banning hemp-derived THC could drive sales underground, making regulation even more difficult. The company hopes to collaborate with lawmakers to ensure adult consumers and veterans can continue accessing these products responsibly.

A recent survey by the Hobby School of Public Affairs at the University of Houston examined public opinion on cannabis policies in Texas. While medical cannabis enjoys the most widespread support, there is also significant backing for more relaxed recreational use laws.

The study found that 69% of Texans favor decriminalizing cannabis possession, and 62% support legalizing recreational use and sales. Although opinions differ across political lines, a majority in both major parties back legalization, with 53% of Republicans and 71% of Democrats in favor.

Support for medical cannabis is even higher, with 79% of Texans believing it should be available with a prescription. Among Republicans, 75% endorse medical cannabis, while 86% of Democrats share this view.

Despite widespread backing for cannabis reform, more than 50% of Texans agree with the governor’s proposed ban on THC-infused consumables, which remain unregulated. The level of support varies across different groups: 61% of Republicans, 70% of Gen Z, 48% of Democrats, and 46% of baby boomers are in favor of restricting these products.

As lawmakers consider the economic and consumer impact of this proposal, the Senate State Affairs Committee will continue to assess the potential consequences of banning THC products in Texas.

The marijuana industry, including leading brands like Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) in other jurisdictions recognize that regulation is important, but lawmakers also need to find ways to regulate marijuana without stifling business.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Washington Lawmakers Again Shelve Initiative to Permit Marijuana Home Cultivation

Washington State lawmakers have once again abandoned an effort to legalize personal cannabis cultivation at home, choosing instead to maintain its felony classification. The proposed legislation, HB 1449, introduced by Representative Shelley Kloba, failed to advance past the House Appropriations Committee before the legislative deadline, effectively halting progress on the measure for this session.

Had it passed, the measure would have permitted individuals aged 21 and over to cultivate up to six marijuana plants at home, with a household limit of 15 plants, regardless of the number of adult residents. The legislation also aimed to allow individuals to keep the cannabis-derived from those plants, even though the state currently only permits possession of up to one ounce.

Kloba and her supporters have been pushing for nearly ten years to enact legislation permitting some home growing, but state agencies and other lawmakers have opposed the plan every year. A similar proposal from Kloba, HB 2194, failed last year. Despite these setbacks, she has repeatedly expressed her determination to continue pushing for reform.

Washington was among the first states to legalize recreational cannabis, approving a ballot measure in 2012. However, growing cannabis at home without a medical license is a Class C felony, which carries a maximum sentence of five years in prison and a $10,000 fine. Attempts have been made to amend this part of the law since 2015, but no proposal has been approved.

This year’s bill gained backing from several cannabis businesses and encountered less resistance from state agencies like the Liquor and Cannabis Board (LCB), which had opposed previous home cultivation initiatives. Despite this shift, Democratic lawmakers were unable to unite in support of the measure.

During a recent committee hearing, Kloba emphasized the importance of updating the law, stating that while Washington legalized many aspects of marijuana use through Initiative 502, home cultivation was not included.

The committee eventually voted to move HB 1449 forward after incorporating three amendments proposed by Representative Christine Reeves. Reeves’s amendments added regulations such as requiring the LCB to create a tracking system for homegrown plants, mandating that cannabis waste be mixed with other household waste for disposal, and establishing fees for those who wish to grow at home.

Additionally, commercial producers would be required to inform consumers about home cultivation laws, and the LCB would have to publish relevant legal information on its website.

One of Reeves’s changes also required liability insurance for anyone considering cannabis cultivation. Another stated that before enforcing home grow regulations, law enforcement should take into account the local availability of legal cannabis and provide a warning for first-time infractions involving plant restrictions.

Training on the history of marijuana enforcement and its disproportionate impact on specific populations would be mandatory for all law enforcement officers. Despite these additions, Reeves remained hesitant about the bill, noting that her constituents do not support the presence of marijuana businesses in their communities.

The marijuana movement, including entities like Canopy Growth Corp. (NASDAQ; CGC) (TSX: WEED), will likely be unhappy that the repeated efforts to reform the legal cannabis industry in Washington State are not registering the success intended to give adults in the state an opportunity to grow their own marijuana if they so choose.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Trump’s Cuts to Funding Put Marijuana Research at Risk

The federal government’s decision to reduce funding for research is jeopardizing 565 cannabis-related studies. In addition, a freeze on new grants from the National Institutes of Health (NIH) is slowing down future studies at a critical time, raising concerns about cannabis policy changes and potential consequences for the industry.

Earlier this month, the NIH announced that there would be a significant cut in research grants allocated for indirect costs, such as facility and administrative expenses, capping it at 15%. Universities responded by filing lawsuits to block the cuts, leading to a temporary halt in their implementation while legal challenges unfold.

Researchers are now left in uncertainty, continuing their work despite the looming threat of funding termination, which could have long-term effects on the $32 billion cannabis industry.

Without solid scientific studies, the legal cannabis sector faces difficulties countering claims about the negative effects of marijuana, including lawsuits concerning high-potency cannabis products. Additionally, without substantial research backing, industry advocates may struggle to persuade legislators who remain skeptical or opposed to marijuana reform, including changes to its federal classification.

While federal grants are not the sole financial resource for marijuana studies, institutions like UCLA receive funding from state marijuana tax revenue. However, in most cases, NIH grants remain essential as they support larger, more impactful research projects.

The federal government has also halted the review process for new studies, leaving many projects stuck indefinitely.

This disruption contradicts previous indications that the administration would take a supportive stance on cannabis and goes against a call made by the National Academies of Sciences, Engineering, and Medicine in September. The organization urged the government to lift existing research restrictions to better understand marijuana legalization’s public health implications.

Although cannabis research accounts for only a fraction of the $47 billion the federal government spends annually on biomedical studies, it has seen significant growth. In 2012, when recreational cannabis was legalized for the first time in Washington and Colorado, researchers published approximately 1,200 cannabis-related studies. By 2021, that number had surged to over 4,200, with an increasing focus on marijuana’s potential benefits rather than just its risks.

The uncertainty surrounding funding could also impact the ongoing cannabis rescheduling process. The DEA has paused rescheduling hearings, with the decision now resting solely in the agency’s hands. If Trump’s choice for DEA director, Terrance Cole, a known marijuana critic, is confirmed as DEA chief, the chances of rescheduling could diminish.

Marijuana businesses like Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) inside and outside the U.S. are likely to take a keen interest in the way Trump’s administration supports or hinders marijuana policy reform at the federal level.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Texas Judge Rejects AG’s Request to Block Dallas’ Cannabis Decriminalization

A judge in Texas has ruled that Dallas can continue implementing a voter-approved measure decriminalizing cannabis, rejecting an effort by the state’s attorney general to halt the policy while a lawsuit against it moves forward.

Judge Dale Tillery denied Attorney General Ken Paxton’s request for a temporary injunction. Paxton sought to block the city from moving forward with the reform, which prevents law enforcement from enforcing marijuana-related criminal penalties. The judge’s brief ruling stated that after reviewing the case’s arguments and evidence, the request for an injunction was denied.

The ruling does not dismiss Paxton’s lawsuit, but it allows the city’s decriminalization policy to remain active as legal proceedings continue. Dallas officials placed the decriminalization measure on the ballot last year after activists gathered enough signatures to qualify it for a vote. The law, passed with strong voter support last year, prevents arrests and citations for possession of up to four ounces of cannabis.

Following the decision, Adam Bazaldua, a Dallas City councilmember, expressed his support, emphasizing that the law was backed by more than two-thirds of voters. He criticized the attorney general’s attempt to overturn the decision, arguing that minority communities had historically faced disproportionate enforcement of marijuana laws.

He stated that voters made a rational choice to redirect law enforcement resources toward more pressing issues and applauded the court’s decision to let the law stand.

Ground Game Texas executive director Catina Voellinger praised the ruling as a win for democracy. She argued that the attorney general should not have the power to override the will of the people. According to Voellinger, the measure was designed to align with state laws, and blocking its enforcement would have harmed the community by allowing unnecessary criminalization to continue.

The decision comes a month after the city’s Police Department announced that officers would stop citing or arresting individuals for possession of small amounts of cannabis per the approved measure.

Paxton had quickly moved to challenge the law in court following the November elections, seeking to overturn it. His lawsuit is part of a broader effort to use the legal system to invalidate similar marijuana reforms in multiple Texas cities.

In previous cases, Paxton attempted to block decriminalization measures in San Marcos, Austin, Killeen, Denton, and Elgin. However, judges have dismissed lawsuits in San Marcos and Austin while Elgin officials settled, noting that decriminalization had not been enforced there despite voter approval.

Cannabis industry firms like Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) will be following how this case in Texas evolves later in the year to see whether local ballot measures to decriminalize marijuana possession can spur change at the state level over time.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Air Force Personnel in Massachusetts Receive Strong Warning on Cannabis Use

Staff at Massachusetts’ Hanscom Air Force Base have been reminded of the stringent rules governing the use and possession of marijuana products on the base.

A recent memorandum clearly states that individuals are prohibited from using, possessing, distributing, or bringing marijuana onto the base. However, the 66th Air Base Group Legal Office emphasizes that this restriction extends to all personnel, including federal employees, military members, dependents, contractors, and anyone attempting to enter the base. The rule also covers CBD and THC-containing products.

The policy aligns with federal law and the Defense Department (DoD) regulations, which classify cannabis as a restricted substance under the Controlled Substance Act (CSA). While CBD is a non-intoxicating compound that can be derived from hemp—a plant legally recognized federally—some CBD products contain trace amounts of THC, making them subject to the ban.

The statement explicitly includes hemp-based products in the prohibition, banning the use, possession, or distribution of any substances derived from hemp.

The Uniform Code of Military Justice (UCMJ) strictly prohibits the wrongful possession and use of controlled substances. Under Article 112A, this includes a range of drugs such as cocaine, heroin, methamphetamine, LSD, and cannabis, among others. Notably, no legal distinction is made between hemp and cannabis, despite federal law defining hemp as marijuana containing no more than 0.3% THC concentrate by dry weight.

Regardless of the legal debate over CBD, those who violate these regulations can face serious consequences under military law. Federal employees may be subject to disciplinary measures outlined in Department of the Air Force Instruction 36-148, which covers actions against civilian personnel. Additionally, federal workers, military personnel, and DoD contractors could be banned from the base or lose their security clearance.

Another factor that could jeopardize security clearance is direct financial involvement in the cannabis industry. The legal office warns that knowingly investing in businesses or stocks related to cannabis cultivation and retail could have negative repercussions.

Despite the strict restrictions, the policy does not extend to hemp-based durable goods such as clothing, which remain permissible.

The ban also applies to Fourth Cliff Annex, FamCamp, Patriot Golf Course, and Sagamore Hill.

The DoD has continuously reaffirmed its opposition to service members and related people using cannabis. Even seemingly innocuous items, such as hemp-based cereal or CBD-infused hand sanitizer, could endanger military readiness, the Air Force said in 2022.

The cannabis industry, including enterprises like Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), looks forward to a time when federal drug laws will evolve so that even service members who need marijuana products, such as medical marijuana, can access them without risking their jobs.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Get Ready for The Pennsylvania Cannabis Convention: A Hub for Cannabis Innovation and Networking

The Pennsylvania Cannabis Convention (“PACC”) is gearing up to bring together growers, traders, brands, and enthusiasts to explore the legal cannabis sector in Pennsylvania on March 30, 2025. This event is a must-visit for those involved in the local cannabis industry, offering attendees in-depth insights into every aspect of the PA medical program. Registrations are open, and PA patients can attend the PACC for free.

For the March 30 event, PACC has partnered with NECANN, a renowned leader in hosting cannabis networking events. NECANN events are recognized as some of the premier cannabis gatherings on the East Coast, providing high ROI B2B opportunities. Each year, these events draw over 9,000 attendees, offering a platform for discovering new business and investment opportunities across the cannabis sector.

The event will take place at the David L. Lawrence Convention Center, covering nearly eight acres of space in downtown Pittsburgh. The venue offers an exceptional environment for events, meetings, and exhibitions, ensuring an unparalleled experience for all attendees.

With the expertise of NECANN, PACC is poised to create a vibrant and sustainable networking and business platform for local cannabis brands, growers, and retailers. The attendee list will include both startups and seasoned cannabis players, as well as key decision-makers within the industry. Exhibitors will have the opportunity to showcase their products and services while pitching their brands across various industry verticals. Licensed cultivators will present their innovative ideas and technologies, while investors can use the platform to discover new investment opportunities. Small businesses and newcomers will also have the chance to connect with industry veterans and forge lasting business relationships.

Ethos, the event’s presenting sponsor, includes a family of brands such as Natural Selections and Eleven, and will provide valuable insights on how enhanced cannabis products can help individuals improve their well-being.

To learn more, please visit https://cnw.fm/RAf2D

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — 2025 Could See University and Marijuana Industry Partnerships Blossoming

The year 2025 is set to mark a turning point in collaborations between universities and the marijuana industry, both in the U.S. and around the world. While partnerships between academia and businesses are nothing new, the marijuana sector has been slow to accept them, largely due to cannabis’ federal illegality in the U.S.

However, as the sector evolves, forming alliances with academic institutions presents an opportunity to influence policy, drive research, and shape the sector’s future.

These collaborations could take many forms, including research initiatives, sponsored studies, and joint ventures. Universities are essential in innovation, while businesses provide the infrastructure and funding necessary for commercial success.

Across the U.S., institutions are responding to the industry’s rapid growth by introducing specialized programs to meet students’ interests. Most of these schools are eager to collaborate with marijuana companies, leveraging their research capabilities, access to medical cannabis patients, and expertise. In return, industry partners contribute their entrepreneurial experience to bring these innovations to the market.

Agricultural schools in the U.S. have taken the lead in forming cannabis-related collaborations, especially in hemp cultivation and research. Universities like Cornell and Clemson have worked alongside hemp farmers to address challenges in pesticide use, genetic engineering, and crop optimization.

With the expansion of medical marijuana across Europe, Germany’s move toward legal recreational use, and the possibility of cannabis being rescheduled in the U.S., it’s time to strengthen ties between the cannabis sector and academia. These partnerships could foster groundbreaking advancements and provide businesses with access to research and patented technologies.

Europe may emerge as the driving force behind a surge in academia-private sector collaborations this year, given its focus on medical marijuana legalization. For businesses looking to enter the European market, working from the medical marijuana approach has become crucial, making academic partnerships a strategic entry point into the highly regulated space.

For instance, Germany’s approach to recreational marijuana sales is more structured and research-oriented compared to the U.S., where medical and recreational sales often overlap. The country recently introduced a pilot program that integrates university research into its framework, similar to models in Switzerland and the Netherlands.

The initiative, set to run for five years in select cities, will closely monitor consumer behavior through partnerships with companies like Sanity Group and Canadian retailer High Tide.

While universities are not directly involved in product commercialization, they are innovation hubs with significant potential for revenue generation through intellectual property. Technology transfer agreements allow institutions to retain control of their research while facilitating commercialization. These collaborations blend academic expertise with business acumen, creating mutually beneficial opportunities for advancing the industry.

Regulatory barriers still limit the extent of these collaborations and available funding, but the potential rescheduling of cannabis in the U.S. could change this dynamic. If rescheduling occurs, it may unlock institutional funding and public-private investments, making 2025 a landmark year for groundbreaking cannabis-related academic collaborations.

One can only watch and wait to see what partnerships, if any, leading cannabis firms like SNDL Inc. (NASDAQ: SNDL) enter into with the academia in order to lay the groundwork for their future products and strategic direction.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Major New Mexico Cannabis Firm Files for Bankruptcy

In spite of the widespread use of cannabis, businesses in the industry have faced significant challenges. Despite the continued growth in retail sales, many brands find it challenging to differentiate themselves in a market that largely views cannabis as a commodity. Even some of the biggest players have filed for bankruptcy due to these difficulties.

A prime example is Planet 13, a well-known cannabis retailer in Las Vegas that features a massive retail space, a restaurant, and a consumption lounge. However, despite its success in Nevada, the company has had trouble replicating that achievement in other locations. No cannabis brand has achieved dominance; rather, most brands resemble generic stores.

One of the key obstacles is pricing. Consumers, who are typically well-informed about cannabis, prioritize the product’s quality—such as its strain and THC content—over brand names. As a result, companies find it difficult to charge premium prices when buyers perceive little difference between brands. Celebrity-backed products, such as those from Tommy Chong or Mike Tyson, often fare better because they leverage name recognition rather than relying on a standalone brand identity.

While demand for marijuana remains strong, brands still face the challenge of convincing consumers to choose them over competitors. This struggle for differentiation has been a major factor in Bright Green Corporation’s recent financial troubles, which recently filed for bankruptcy.

Bright Green Corporation, founded in 2019 and based in New Mexico, specializes in the production of legal marijuana and marijuana extracts. The company operates in manufacturing, research, and medical marijuana production.

Unlike most other cannabis businesses that have gone bankrupt, Bright Green Corporation has found a way forward. The company has reached a Restructuring Support Agreement (RSA) with Lynn Stockwell, a key shareholder, to facilitate a reorganization. Under this agreement, Stockwell will take over as CEO upon court approval. The restructuring plan includes a 1-for-50 reverse stock split and provisions for unsecured creditors to receive a mix of equity and cash.

Stockwell, who also founded Drugs Made in US Acquisition Corp I and II, aims to bring pharmaceutical ingredient manufacturing back to the U.S.

The company is the first publicly traded company in the U.S. to have direct involvement with marijuana cultivation. It plans to collaborate with the HHS to support cannabis research at its New Mexico facility. Additionally, it is exploring a franchise model to expand its agricultural operations in Central New Mexico, East Arizona, and West Texas.

As the marijuana industry matures in different jurisdictions, mergers and acquisitions, bankruptcies and other hallmarks of market consolidation are bound to become increasingly common. It is now up to leading brands like Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) to study the evolving market and position themselves appropriately to benefit from these shifts.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com